Medicare can pay for obesity drugs like Wegovy in certain heart patients
Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday.
The Centers for Medicare & Medicaid Services issued new guidance that says Medicare Part D drug benefit plans — which are offered through private insurers — could cover anti-obesity drugs that are approved for an additional use.
The move could pave the way for thousands of new prescriptions, resulting in billions of dollars in increased spending, analysts have said.
In practice, the guidance opens the door to wider coverage of Wegovy, the brand name of Novo Nordisk’s obesity medication semaglutide. The U.S. Food and Drug Administration this month approved a label change that allows Wegovy to be used to reduce the risk of cardiovascular events in people who are overweight or have obesity and also have existing heart disease.
Related articles
FDA brings lab tests under federal oversight in bid to improve accuracy and safety
WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have abou2024-04-30New York man pleads guilty to sending threats to state attorney general and Trump civil case judge
NEW YORK (AP) — A New York man has pleaded guilty to sending death threats to the state attorney gen2024-04-30Rybakina, Vondroušová into Stuttgart quarters while Jabeur out
STUTTGART, Germany (AP) — Fourth-seeded Elena Rybakina battled her way into the Porsche Grand Prix q2024-04-30A Nigerian schoolgirl abducted by extremists 10 years ago is rescued pregnant and with 3 kids
ABUJA, Nigeria (AP) — A girl who was seized from her school along with hundreds others during a raid2024-04-30Goodbye to Scotland's answer to Liz Truss: How Sturgeon's short
Humza Yousaf bowed out as SNP leader today after fewer than 400 crisis and gaffe-filled days in char2024-04-30Inside luxury brands' STAGGERING price hikes
Just over a decade ago, owning a medium classic Chanel flap bag seemed like an attainable feat.Altho2024-04-30
atest comment